Ryaltris (olopatadine hydrochloride and mometasone furoate)

**Product type:** Human Prescription Drug

**Active ingredient:** MOMETASONE FUROATE MONOHYDRATE; OLOPATADINE HYDROCHLORIDE

**Strength:** 25; 665 ug/1; ug/1

**Dosage form:** Spray, Metered

**Route:** Nasal

**Labeler:** Glenmark Pharmaceuticals Inc., USA

**Marketing category:** NDA (NDA211746)

**Pharmacologic class:** Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Decreased Histamine Release [PE], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Histamine-1 Receptor Inhibitor [EPC], Mast Cell Stabilizer [EPC]